Literature DB >> 18581145

Renal function in children with beta-thalassemia major and thalassemia intermedia.

Vladislav Smolkin1, Raphael Halevy, Carina Levin, Miguel Mines, Waheeb Sakran, Katzap Ilia, Ariel Koren.   

Abstract

In beta-thalassemia, profound anemia and severe hemosiderosis cause functional and physiological abnormalities in various organ systems. In recent years, there have been few published studies demonstrating proteinuria, aminoaciduria, low urine osmolality, and excess secretion of the tubular damage markers, such as urinary N-acetyl-D-glucosaminidase (U(NAG)) and beta2 microglobulin, in patients with thalassemia. The object of this study was to analyze renal tubular and glomerular function in pediatric patients with beta-thalassemia and to correlate the renal findings to iron overload. Thirty-seven patients with beta-thalassemia major and 11 with thalassemia intermedia were studied. Twelve children without iron metabolism disorders or renal diseases served as a control group. No difference in blood urea nitrogen (BUN), serum creatinine, creatinine clearance, electrolytes, fractional excretion of sodium and potassium, and tubular phosphorus reabsorption was found. Serum uric acid was equal in the two groups, but its urine excretion was significantly higher in the thalassemic group. U(NAG) and U(NAG) to creatinine ratio (U(NAG/CR)) were elevated in all patients with thalassemia compared with the control group (p < 0.001) and were directly correlated to the amount of transfused iron but not to actual ferritin level. We found that renal tubular function is impaired in children with beta- thalassemia major and intermedia. It is not known whether these functional abnormalities would have any long-term effects on the patients. Further studies are needed, and means of preventing these disturbances should be sought.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581145     DOI: 10.1007/s00467-008-0897-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  27 in total

1.  Function of the kidney in adult patients with Cooley's disease. A preliminary report.

Authors:  F Mastrangelo; T Lopez; S Rizzelli; G Manisco; C Corlianò; L Alfonso
Journal:  Nephron       Date:  1975       Impact factor: 2.847

2.  Renal function in pediatric patients with beta-thalassemia major.

Authors:  B Aldudak; A Karabay Bayazit; A Noyan; A Ozel; A Anarat; I Sasmaz; Y Kilinç; E Gali; R Anarat; N Dikmen
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

3.  Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis.

Authors:  B H Landing; H C Gonick; R L Nadorra; C B Hyman; T R Wells; G Villarreal-Engelhardt; J Mersch; C L Agness
Journal:  Pediatr Pathol       Date:  1989

4.  Effect of iron loading on transmembrane potential, contraction, and automaticity of rat ventricular muscle cells in culture.

Authors:  G Link; P Athias; A Grynberg; A Pinson; C Hershko
Journal:  J Lab Clin Med       Date:  1989-01

5.  Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy.

Authors:  P Cianciulli; D Sollecito; F Sorrentino; L Forte; E Gilardi; A Massa; G Papa; S Carta
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

6.  Ferritin and superoxide-dependent lipid peroxidation.

Authors:  C E Thomas; L A Morehouse; S D Aust
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

7.  Renal tubular dysfunction in alpha-thalassemia.

Authors:  Achra Sumboonnanonda; Prida Malasit; Voravarn S Tanphaichitr; Sompong Ong-ajyooth; Siripan Petrarat; Arun Vongjirad
Journal:  Pediatr Nephrol       Date:  2003-02-26       Impact factor: 3.714

8.  Phosphaturia in thalassemia.

Authors:  P Lapatsanis; S Sbyrakis; C Vertos; B A Karaklis; S Dosiadis
Journal:  Pediatrics       Date:  1976-12       Impact factor: 7.124

9.  Acute changes in renal function associated with deferoxamine therapy.

Authors:  G Koren; Y Bentur; D Strong; E Harvey; J Klein; R Baumal; S P Spielberg; M H Freedman
Journal:  Am J Dis Child       Date:  1989-09

Review 10.  Clinical application of deferasirox: practical patient management.

Authors:  Elliott Vichinsky
Journal:  Am J Hematol       Date:  2008-05       Impact factor: 10.047

View more
  20 in total

1.  Renal tubular function and urinary N-acetyl-β-d-glucosaminidase and kidney injury molecule-1 levels in asthmatic children.

Authors:  Ayşegül Doğan Demir; Nilufer Goknar; Faruk Oktem; Emin Özkaya; Mebrure Yazıcı; Emel Torun; Aysel Vehapoğlu; Mehmet Kucukkoc
Journal:  Int J Immunopathol Pharmacol       Date:  2016-06-07       Impact factor: 3.219

Review 2.  Renal complications of beta-thalassemia major in children.

Authors:  Ashraf Bakr; Youssef Al-Tonbary; Ghada Osman; Rasha El-Ashry
Journal:  Am J Blood Res       Date:  2014-09-05

3.  GFR in Patients with β-Thalassemia Major.

Authors:  Gai Milo; Revital Feige Gross Nevo; Idit Pazgal; Anat Gafter-Gvili; Ofer Shpilberg; Uzi Gafter; Arie Erman; Pinhas Stark
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-11       Impact factor: 8.237

Review 4.  Association of chromosome damage detected as micronuclei with hematological diseases and micronutrient status.

Authors:  Ashutosh Lal; Bruce N Ames
Journal:  Mutagenesis       Date:  2011-01       Impact factor: 3.000

5.  Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman.

Authors:  Waad-Allah S Mula-Abed; Huda S Al-Hashmi; Muhanna N Al-Muslahi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

6.  Deferasirox-induced renal impairment in children: an increasing concern for pediatricians.

Authors:  Laurence Dubourg; Céline Laurain; Bruno Ranchin; Corinne Pondarré; Aoumeur Hadj-Aïssa; Dominique Sigaudo-Roussel; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2012-04-24       Impact factor: 3.714

7.  Renal dysfunction in patients with thalassaemia.

Authors:  Charles T Quinn; Valerie L Johnson; Hae-Young Kim; Felicia Trachtenberg; Maria G Vogiatzi; Janet L Kwiatkowski; Ellis J Neufeld; Ellen Fung; Nancy Oliveri; Melanie Kirby; Patricia J Giardina
Journal:  Br J Haematol       Date:  2011-02-21       Impact factor: 6.998

8.  Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.

Authors:  Maria G Vogiatzi; Eric A Macklin; Felicia L Trachtenberg; Ellen B Fung; Angela M Cheung; Elliott Vichinsky; Nancy Olivieri; Melody Kirby; Janet L Kwiatkowski; Melody Cunningham; Ingrid A Holm; Martin Fleisher; Robert W Grady; Charles M Peterson; Patricia J Giardina
Journal:  Br J Haematol       Date:  2009-07-13       Impact factor: 6.998

9.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study.

Authors:  Enas A Hamed; Nagla T ElMelegy
Journal:  Ital J Pediatr       Date:  2010-05-25       Impact factor: 2.638

10.  Comparing different markers of tubular dysfunction in transfusion-dependent thalassemia patients.

Authors:  Ilham Youssry; Samuel Makar; Khalil Abdelkhalek; Dina Hisham; Happy Sawires
Journal:  Int Urol Nephrol       Date:  2021-06-24       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.